Tetrapeptides of pdmary sequence Tyr-X-Phe-YNH 2, where X Is D-Cys or D-Pen (peniclllamlne) and where Y Is D-Pen or L-Pen, were prepared and were cyclized via the side chain sulfurs of residues 2 and 4 to disulfide or dithioether-contalning analogs. These peptldes are related to previously reported peniclllamine-contalning pentapaptide enkephalin analogs but lack the central glycine residue of the latter and were designed to assess the effect of decreased dng size on oploid activity. Binding affinities of the tetrapeptides were determined to both /J and ~; oploid receptors. Binding affinity and selectivity in the tetrapaptlde sed~s were observed to be highly dependent on pdmary sequence. For example, L-Pen a r~.ogs dismayed low affinity and were nonselective, while the corresponding D-Pen diastereomers were of variable affinity and higher selectivity. Among the latter compounds were examples of potent analogs in which selectivity shifted from 6 selective to/~ selective as the dng size was increased. The relatively high binding affinity and 6 receptor selectivity observed with one of the carboxamide terminal disulfide analogs led to the synthesis of the corresponding carbox~ic acid terminal, Tyr-D-Cys-Phe-D-PenOH. This anal,~)g displayed 6 receptor binding selectivity similar to that of the standard 6 ligand, [DPen'~,D-Pen"]enkephalin (DPDPE), and was found to have a 3.5-fold higher binding affinity than DPDPE. All the tetrapeptides were further evaluated in the isolated mouse vas deferens ( mvd ) assay and all displayed opioid agonist activity. In general, tetrapaptide potencies in the mouse vas deferens correlated well with binding affinities but were somewhat lower. Receptor selectivity in the mvd, assessed by examining the effect of opioid antagonists on the tetrapaptide concentration-effect curves, was similar to that determined in the binding studies.
In this series ~ receptor binding affinity and selectivity were observed to decrease with increasing ring size (4).
Schiller and coworkers have reported a series of smaller, cyclic des-Gly 3 enkephalin tetrapeptides in which cycllzatlon is effected by amlde bond formation via side chain functions of residues 2 and 4 (5,6). Within this series are members which display considerable /= oploid receptor selectivity resulting primarily from reduced 6 receptor affinity. In view of this finding and our studies on expanded rtng size In the pentapaptlde series, we undertook an Investigation of the effect of ring contraction on oploid recep(or affinity and selectivity In a series of des-Gly ° disulfide-and dlthloether-contalnlng tetrapaptides of general structure: Several analogs In this series have Interesting oploid receptor binding profiles. Particularly noteworthy among these Is an analog which exhlbCs higher ~ receptor affinity than the bis-penicHlamine enkephalins while rnalntalnlng comparable selectivity.
Methods
Peotlde synthesis. All pep(Ides reported here were prepared by solid phase methods slmgar to those pr~ described (2,4,7). Chloromethylated poh/styrene (Merrlflald) resin crossllnked with 1% dMnylbenzene was used for the synthesis of peptides with carboxy terminal carboxylic acid functions, while p-methyll:~nzhydry4amlne resin was used for the synthesis of carboxamide terminal pep(ides, tBut~oxycartx:~yl protection of ~.-amlno functions was used throughout, while S-p-methylbenzyt protection was used for the labile side chain sulfurs of Cys and Pen. In all cases the linear free-sulfhydryl containing paptides were generated by treatment of the paptide-resin with anhydrous HF In the preset'me of 5% anlscle and 5% dlthlo~hane, as has been previously descdbed (2). Pdor to cyclizatlon, the linear, free sulfhydrytcontaining pap(ides were purified by reverse phase-high performance liquid chromatography (RP-HPLC) on a Vydac 218TP C-18 column (2.5 x 22cm) using the solvent system 0.1% trlfluoroacetlc acid ('I'FA) In H20 / 0.1% TFA In acetonltrle. A gradient of 10-50% organic component over a course of 40 mln was employed for all purifications. Disulfide containing analogs were prepared by treating an aqueous solution ( pH 8.5 ) of the corresponding free sulfhydry|-contalning species with K3Fe(CN)6 (2), while dlthloether-containlng analogs were obtained by treating a dlfute solution of the free suil'nydr~-contalning peptide in dimethyt formamide with potassium tert-butoxide followed by addition of the appropriate alkyl dibromide (4). Disuffide and dltldoether-containlng pep¢ides were purified by RP-HPLC as described above. Purity of the final product paptldes was assessed by analytical HPLC monitored at 280nm and at 23Ohm. All pap(ides were >98% pure by rids measure. Analytical evaluation of the final paptides also Included testing with 5,5'-dithiobis-(2-nltrobenzolc acid) to detect the presence of free sulfhydryl groups (8). Final confim~tion of the putative structures was ol0talnad by fast atom bombardment-mass spectrometry which ytelded the appropriate molecular weights for all of the peptldes.
Receotor bindlrm essava. The binding assays, based on the displacement by the test compounds of redldebelled sufentanl ~ Ilgand) or DPDPE (~ I~nd) In cerebral membranes from rat brain, were perf~ as previously described (9,10). Briefly, the assay mixture, containing membrane suspan~on In 50mM Trls buffer (oH 7.4), 150mM NaCI, the radlofabeged liga~l and the test compound, wa~ incubated to reach bindlog equilibrium (40min for assays using 0.5nM [°H] sufentanll; 60min for 1.5nM ['~H]DPDPE) at 25°C. Subsequently, the samples were rapidly filtered and the radioactivity on the filter determined by liquid scintillation counting. Inhibition of radiolabelled llgand binding by the test compound was computed from maximal specific binding, determined with an appropriate excess of unlabelled sufentanil or DPDPE. IC50 values were obtalnad by linear regression from plots relating Inhibition of the specific binding In probit units to the log of five diffarent Ilgand concentrations (9). In every case the correlation coefficient, r'-, of the Iogprol04t plot was higher than 0.97.
Iso4ated mouse vas defarens tmvd~ assav. The mvd assays were performed as previously described (11). Briefly, 1.5cm yes defarens segments from male, albino ICR mice were suspended in organ baths which contained 30mL of a modified Krebs' buffer (118mM NaCI, 4.75mM KCI, 2.54mM CaCI 2. 1.19mM MgSOA, 1.19mM KHgPO 4, 11mM glucose, 25mM NaHCOR, 0.3mM pargyllna HCI, 0.2mM tyrosina, 0.1mM ascorb]c acid, and (~.03mM sodium EDTA) saturated witR 95% 0 2 -5% CO 2 and kept at 37°C. The segments were attached to strain gauge tmneducers and suspended between two platinum electrodes. After a 30mln equilibrium period, the segments were stimulated once every 10s with pairs of pulses of 2ms duration, 1 ms apart end at supramaxlmal voltage. Test compounds were evaluated for their ability to Inhibit the alectdcally stimulated smooth muscle contmctlona in this preparation. One vas deferens of each pair of vase defarentla was studied In the presence of either 100nM naltrexone or 100nM ICI-174864 and the other served as the control. IC¢,n values were determined by problt analysis and values reported are the means of 3-9 detarmlnations. Because there were no appreciable differences among the IC£~2 values for the control preparations studied with either naitrexone or IC1-174864, the control IC,~. reported for each agonlst Is the mean of all control values determined in experiments with both antagonists.
Results
The binding affinitiss of eleven cyclic tetrapaptldes to p and ~; op4okl receptor~ln brain membranes as datermlned by the.abiflty of the test compounds to dlsp4ace the /= selective Ilgand [°H] sufentanll and the ~; selective ligand [°H]DPDPE (9) are listed I~ Tabie I. 4~Jso i~rovlded are the corresponding values for the reference p ligands sufentenU and [D-hJa , NMePhe , Gly°-ol]enkephelln (DAGO) and the reference llgand DPDPE. The Initial tetrapaptldes chosen for synthesis were those which had a carboxamlde terminal penlclllamlne residue, D-Cys or D-Pen as the second residue, and which were cyclized to either the disulfide or ethylene dlthloether. Such a sedes would allow direct compadson with both the dlsuffide-containlng pentapeptldes such as DPDPE as well as the highly # receptor selective cyclic tatrapeptide, Tyr-O-Orn-PheAspNH , reported by Schiller and coworkers (5,6) which, like the ethylene dithloathers, contains a 13-memi~'ed dng. Unlike the analogs reported here, however, Schlller's analog Is cydized via an amlde bond between the ornlthine 6-amino group and the aspartlc acid ~-carboxylate function.
The carboxamlde terminal tet]apaptldes 1-7 end 9 display several Interesting features. Within this series, analogs ~-~ which have a L-Pen" residue, display rather low affinity and ere essentially devoid of receptor selectivity in the binding essay. In contrast co~lng analogs with a D-Pen" residue (.t,2,Z and ~) exhibit considerable variation In both affinity and selectlv#y. For example, analogs 1 and Z show significant 6 receptor selectivity with Z disp~aying considerable affinity for the 6 receptor. However, analog ~, which contains the same pdmary sequence as 7 but which is cyclized as the ethylene dlthioethar rather then the disuiffde, is significantly # receptor selective and displays a 2.4-fold higher affinity for # receptor binding sites then does the prototypioal , ligand, DAGO. The result of altering the dng size by two carbon atoms between analogs 7 and 9 Is a 130-fold shift in selectivity.
The stdldng selecthdty shift seen between 7 and 9 as a result of altedng the dng size was further explored by preparing the methylene-dithloather (actually, a dithioacetal) analog, 8. and the propyfenedlthloether analog, 10. Analogs Z-10 thus represent a subsedes In which primary sequence is maintained Binding assays were performed on rat brain membrane preparations as described in Methods. Reported IC50 values represent the mean of 1-6 experiments run in duplicate with 5 different concentrations of each compound. The average range (n < 4) or standard deviation (n ~ 4) for the/= and 8 selective assays was _+ 6.5% and +_ 10%, respectively (9).
while ring size Is vaded from an 11 -mernbered ring to a 14-membered dng. Increasing the dng size from the 11 -membered dng In 7 to the 12-membered ring of 8 Increases p receptor affinity 4-fo~d while decreasing 6 receptor affinity by a factor of 14 (Table I) . As a result, analog 8 exhibits a slight binding preference for # opioid receptors. Increasing the dog size by an additional carbon results in a slight improvement in # receptor selectivity for analog 9 as compared with analog 8. Accompanlng this Improved selectivity are impressive 6-fold and 13-fold enhancements In 6 and # receptor binding affinities, respectively. Further expanding the ring size to the propylene-dithioether, 10, has little effect on selectivity but results in a 4-fold reduction in binding affinity.
The results obtained with analogs .~4,~and ~, which contain 13-membered ring systems, are quite different from those observed for Schlller's analogous tetrapaptide. In the current series analogs 4 and which like Schiller's contain an L-amino acid in position 4, show very weak binding affinity and are essentially nonselective. Only analog 9 among those with a 13-membered ring displays /~ receptor binding selectivity and this salectlvity Is modest. The high # affinity of this analog is nonetheless Indicative of a favorable conformation for # receptor binding. That the analogs presented here differ In binding profile from those reported by Schiller is not surprising given the different stedc and electronic characteristics expected for these analogs.
The significant 6 receptor selectivity of analogs 1 and 7 and the relatively high ~ receptor affinity of the latter are reminiscent of eadiar results in the pantapaptlde panicillamine~ontalnlng enkephalln series in which carboxamlde terminal analogs were obsecved to display 6 receptor selectivity (12). Since carboxylic acid terminal enkephalin analogs are generally ~ed to exhibit considerably enhanced 6 selectivity, the results obtained for analogs ! and Z suggested that the corresponding carboxyllc acid terminal analogs, particularly that of analog 7. might lead to greatly Improved 6 selectivity and/or binding affinity. As shown in Table I this is In fact the case; analog 11 shows greatly Improved 6 receptor salectivlty and affinity compared to analog 7. Indeed, analog 11 is almost as selective as DPDPE, the current standard for 6 receptor selectivity, and has 3.5-fold higher affinity for 6 receptors.
The oploid tetrapeptldes were further evaluated on the isolated, electrically stimulated mouse vas deferens preparation and were compared to DAGO and DPDPE (Table ll) . Both DAGO and DPDPE were full agonists in this assay with DPDPE exhibiting approximately 15-fo~d higher potency then DAGO. All but three of the tetrapeptldes were full agonists which produced complete inhibition of the twitch. Analogs 2, 4, and 10 were partial agonlsts which produced maximal Inhibitions of 85.1 + 2.1%, 65.8 _+ 3.8%, and 91.9 -+ 2.0%, respectively. The most potent in this sedes in inhibiting the twitch was analog 11 which was essentially equlpotent with DPDPE. Analog 9 had about one-half the potency and analog 8, about one-eighth the potency of DPDPE. All other analogs were less potent then DAGO as agonlsts in this preparation, and the partial agonlsts, analogs 2 and 4 were the least potent of the series. Because of the much lower potency of analog 2 on the vas deferans then in the binding assay, this paptide was evaluated as a possible antagonist, however no such activity was observed.
In on:let to determine the types of opioid receptors which mediate the agonlst activity of the tetmpeptlde analogs, complete concentration-effect relationships were determined In the presence and absence of two oplofd antagonists, naltrexone, which is somewhat more salective for /~ receptors then for 6 receptors In the mouse vas deferens (11), and IC1-174864, which Is a highly selective antagonist at ~ oploid receptors and is virtually devoid of activtty at /~ receptors (13). Naltrexone (100nM) caused a 27.4-fold shift to the right in the DAGO concentration-effect curve which is typical of those shifts seen with highly selective # receptor agonlsts (14). In the presence of 100nM IC1-174864, there was no shift in the DAGO concentration-effect curve. In contrast, naltrexone produced a smaller shift In the DPDPE cormentration-effect curve (7.1-fold), and IC1-174864 sJgnlficantly shifted the DPDPE concentration-effect curve to the right (2.8-fo~d).
Three of the tetrapaptlde analogs appeared to be even more selective then DPDPE for 6 receptors in the mouse vas deferens. TI~ shifts produced by 100nM naltrexone and 100nM IC1-174864 were 5.7-and 4.5-fold for analog 11, 3.2 and 4.8-fold for analog !, and 3.9-and 4.0-fo~d for analog 7. respectively. These results are In qualitative agreement with the discdacament studies which found these analogs to exhibit the highest 6 binding selectivity In the series. Two of the tetrapaptlde analogs appeared to act only on p recel~ors in the vas deferens. The shifts produced by 100nM naltrexone and 100nM IC1-174864 were 5.2-and 1.0-fold for analog 10 and 41.3-and 1.2-fold for analog 9. Again these results are In agreement with the displacement results which established analogs 9 and 10 as hevlng the highest # binding selectivity In this series. Both antagonists shifted responses to analog 4 to such a degree that IC50 values could not he rellabiy determlnad, while naither antagonist produced an appreciable shift In the concentration-effect curve of analog 2. Both of these analogs were partial agonlsts of extrame/y low potency. The Interactions with the two antagonists suggested that the remaining tetmpeptides had significant activity at both p and 6 receptors, which, again, is consistent with the results of the binding assays.
Discuesk;ql
As noted above analogs 3-~ which have a carboxy terminal L-Pen resldye, have low opioid binding affintty and are essentially nonselective. In contrast, the corresponding D-Pen" analogs display significant receptor selectivity and, except for ;~, have higher binding affinities. This Is particularly evident In analog Z, which has p receptor binding affinity like that of analog 5 but which has 6 receptor blndlog affinity 22.-fold higher than 5. Similarly, analog 9 has 5.6 and 53-fo/d higher affinity than analog 6 for S and p receptors, respectively. Potencies In the mvd assay parallel the binding results, with analog 7 exhibiting 7.7-fo4d higher potency than 5 and analog 9 disp/aying 35Jold higher potency than 6. Further, while analogs 5 and 6 are relatively nonselective based on antagonist shifts In the mvd, analog Z appears to be selective for ~ and analog ~ selectlva for /J receptors in this preparation. These findings suggest a requirement for a carboxyterminal D-amino acid for optlmel binding to both 6 and /= receptors In this series, a more stringent condition than Is found In the penlclgamine-contalnlng pentapeptide series (1-3). Such a divergence of effect due to altering the configuration of the carboxy terminal residue may be due to the Increased rigidity resulting from the elimination of the glyclne residue in the tetrapeptlde series. In the pentapaptide sedes this flexible glycine residue has been suggested to serve as a means of achieving a similar topography for the various analogs In the series (15). The lack of such a flexible hinge In the tetrapeptide series eliminates much of this conformatlonal compensation.
The changes in receptor binding selectivity observed among analogs Z-.I_~ In which the flng size is varied from 11-to 14-rnembered without altedng the pdmary sequence, also reflect the Importance of conformation on pharmacological activity. As was seen In a sedes of dithicether-contalnlng pentapeptides derived from DPDPE and DPLPE, increasing the ring size in the tetrapaptide series diminishes 6 receptor selectivity (4). In the pentapeptide series, however, this resulted from a large decrease In 6 receptor affinity with little effect observed on p receptor affinity. By contrast, In analogs 7-10 increasing ring size leads to greatly enhanced p, receptor binding affinity (and consequent p receptor selectivity), particularly In 9, while 6 receptor affinity Is more varlabie. Nonetheless, the general trend previously observed, namely that more compact conformations tend to favor 6 receptor binding selectivity, is supported by the data presented here. The observed changes In binding selectlvltles In analogs 7-10 are in agreement wtth the behavior of these analogs In the mvd preparation. As seen from the antagonist shifts presented in Table II , analog 7 displays high 6 selectivity in the mvd while 9 and 10 act prtmanly on # receptors in this assay.
We have previously proposed that the high 6 receptor selectlvi~y of DPDPE is due In part to adverse steric Interactions between the ~, ~-dlmethyt substituents of the Pen': residue and the receptor binding site which decrease binding affinity to ~ and particularly to p receptors (4,15). Further evidence is seen In the current series from a comparison of binding affinities of analog 2 with analog 9. In these ethylene-dithloether analogs, analog 2, which has a D-Pen residue in position 2, has 5.4-fold and 280-fold lower affinity at o ~ and /J receptors, respectively than does analog 9. This result, which is similar to !pt observed with the pentapeptides, DPDPE and DCDPE, reflects adverse sterlc Interactions of the D-Pen 8,/3-dlmathyt groups particularly at /J receptor binding sites. It should be noted that the disulfide-containing analogs .1. and 7 show a much less impressive steric effect due to the side chain of residue 2. In this case the /~, .8-dimethyls of residue 2 in analog .1_ result in approximately 4-fold reductions In binding affinity to both 6 and p receptors. In both analogs, p receptor binding affinities are low suggesting that these more compact structures may lead to adverse steric (or other) interactions with the p receptor which are not observed in more extended structures such as 9.
The design of analog 11 was, as Indicated above, straightforward given the observed 6 receptor selectMty and potency of the carboxamlde terminal analog Z. The resulting high selectivity (similar to that of DPDPE) and high ~ affinity (3.5 folcl higher than that of DPDPE) dismayed by analog 11 are Impressive. The Improved affinity may prove to be useful for In ~lvo experiments. Perhaps of greater significance, analog 11 provides an Important tool for elucidating the optimal ligand conformation for 5 opiokl receptor binding. Since both 11 and DPDPE must assume simgar conformations at the 6 binding site, comparisons of poesibie conformations for these two compounds should allow the elimination of unlikely binding conformations and greatly facilitate the determination of the optlrnal ligand conformation at the ~ opiold receptor.
